Jazz Pharmaceuticals (JAZZ) Revenue Growth (3y) (2013 - 2026)
Jazz Pharmaceuticals (JAZZ) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,583.17 Bn | 67,582.89 Bn | - | - |
| 2 | Nanobiotix | 1,947.22 Bn | 1,947.15 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.21 Bn | 468.42 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 123.29 Bn | 116.04 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.63 Bn | 51.45 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.79 Bn | 37.79 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 15.88 Bn | 14.04 Bn | 934.80 Mn | 6.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.18% |
| Dec 31, 2025 | 7.21% |
| Sep 30, 2025 | 6.18% |
| Jun 30, 2025 | 3.88% |
| Mar 31, 2025 | 3.33% |
| Dec 31, 2024 | 6.66% |
| Sep 30, 2024 | 7.97% |
| Jun 30, 2024 | 10.84% |
| Mar 31, 2024 | 14.08% |
| Dec 31, 2023 | 14.99% |
| Sep 30, 2023 | 17.39% |
| Jun 30, 2023 | 19.40% |
| Mar 31, 2023 | 18.63% |
| Dec 31, 2022 | 18.67% |
| Sep 30, 2022 | 20.49% |
| Jun 30, 2022 | 20.43% |
| Mar 31, 2022 | 16.99% |
| Dec 31, 2021 | 23.47% |
| Sep 30, 2021 | 21.32% |
| Jun 30, 2021 | 14.53% |